1 | combination | 36,281 |
2 | concomitance | 14 |
3 | non-acei/arb | 8 |
4 | floating-needle | 7 |
5 | peripheralization | 7 |
6 | coformulation | 6 |
7 | 'comparison | 5 |
8 | co-delivery | 4 |
9 | nectaries | 4 |
10 | 12-sessions | 3 |
11 | chop-rit | 3 |
12 | glutamine-group | 3 |
13 | hetero-oligomer | 3 |
14 | induction/consolidation | 3 |
15 | late-intervention | 3 |
16 | tone-emitting | 3 |
17 | 1-hydroxylation | 2 |
18 | 1-year-long | 2 |
19 | 3d-framework | 2 |
20 | aminonucleoside | 2 |
21 | co-contaminant | 2 |
22 | co-diagnosis | 2 |
23 | co-vaccination | 2 |
24 | day-6 | 2 |
25 | design/execution | 2 |
26 | exercise/music | 2 |
27 | half-dose-combination | 2 |
28 | macrolid | 2 |
29 | millisievert | 2 |
30 | quinolone-3-carboxamide | 2 |
31 | rifabutin-containing | 2 |
32 | three-spasm-needle | 2 |
33 | two-combination | 2 |
34 | vegfr-tki-based | 2 |
35 | 'oncological | 1 |
36 | 1,3-diene | 1 |
37 | ace-i-based | 1 |
38 | adjunct/combination | 1 |
39 | ag013-subjects | 1 |
40 | ampirical | 1 |
41 | anthracycline/taxane-containing | 1 |
42 | anti-invadopodia | 1 |
43 | anti-microsporidial | 1 |
44 | azaindolyl-maleimides | 1 |
45 | belatacept- | 1 |
46 | bmmsc-based | 1 |
47 | calcitriol- | 1 |
48 | children.combination | 1 |
49 | chronopharmaceutical | 1 |
50 | cilastatin-treated | 1 |
51 | deferasirox-ambisome | 1 |
52 | dietary-behavioral | 1 |
53 | ektachem | 1 |
54 | eortc-radiation | 1 |
55 | exposure/extinction | 1 |
56 | fluid-replacement | 1 |
57 | going-on | 1 |
58 | government/foundation-funded | 1 |
59 | h.pylori-eradicated | 1 |
60 | hdm/sct-only | 1 |
61 | hypocholesterolic | 1 |
62 | immunoresolvents | 1 |
63 | infiusion | 1 |
64 | medical-expulsive | 1 |
65 | mortality.diabetes-specific | 1 |
66 | ngf-based | 1 |
67 | oncolgical | 1 |
68 | oncology/infection | 1 |
69 | other-endocrine | 1 |
70 | phocid | 1 |
71 | photodynamic/radiation | 1 |
72 | post-bmv | 1 |
73 | pre-nutrition | 1 |
74 | pretargeted | 1 |
75 | protocol-prescribed | 1 |
76 | rage-oriented | 1 |
77 | ribavirin- | 1 |
78 | rt-adjuvant | 1 |
79 | stem-based | 1 |
80 | tacrolimus-minimization | 1 |
81 | third-ranking | 1 |
82 | thrombolytic-therapy-based | 1 |
83 | tmz-combination | 1 |
84 | tranvesical | 1 |
85 | who-multidrug | 1 |
86 | whole-planned | 1 |
1 | 'comparison | 5 |
2 | 'oncological | 1 |
3 | 1,3-diene | 1 |
4 | 1-hydroxylation | 2 |
5 | 1-year-long | 2 |
6 | 12-sessions | 3 |
7 | 3d-framework | 2 |
8 | ace-i-based | 1 |
9 | adjunct/combination | 1 |
10 | ag013-subjects | 1 |
11 | aminonucleoside | 2 |
12 | ampirical | 1 |
13 | anthracycline/taxane-containing | 1 |
14 | anti-invadopodia | 1 |
15 | anti-microsporidial | 1 |
16 | azaindolyl-maleimides | 1 |
17 | belatacept- | 1 |
18 | bmmsc-based | 1 |
19 | calcitriol- | 1 |
20 | children.combination | 1 |
21 | chop-rit | 3 |
22 | chronopharmaceutical | 1 |
23 | cilastatin-treated | 1 |
24 | co-contaminant | 2 |
25 | co-delivery | 4 |
26 | co-diagnosis | 2 |
27 | co-vaccination | 2 |
28 | coformulation | 6 |
29 | combination | 36,281 |
30 | concomitance | 14 |
31 | day-6 | 2 |
32 | deferasirox-ambisome | 1 |
33 | design/execution | 2 |
34 | dietary-behavioral | 1 |
35 | ektachem | 1 |
36 | eortc-radiation | 1 |
37 | exercise/music | 2 |
38 | exposure/extinction | 1 |
39 | floating-needle | 7 |
40 | fluid-replacement | 1 |
41 | glutamine-group | 3 |
42 | going-on | 1 |
43 | government/foundation-funded | 1 |
44 | h.pylori-eradicated | 1 |
45 | half-dose-combination | 2 |
46 | hdm/sct-only | 1 |
47 | hetero-oligomer | 3 |
48 | hypocholesterolic | 1 |
49 | immunoresolvents | 1 |
50 | induction/consolidation | 3 |
51 | infiusion | 1 |
52 | late-intervention | 3 |
53 | macrolid | 2 |
54 | medical-expulsive | 1 |
55 | millisievert | 2 |
56 | mortality.diabetes-specific | 1 |
57 | nectaries | 4 |
58 | ngf-based | 1 |
59 | non-acei/arb | 8 |
60 | oncolgical | 1 |
61 | oncology/infection | 1 |
62 | other-endocrine | 1 |
63 | peripheralization | 7 |
64 | phocid | 1 |
65 | photodynamic/radiation | 1 |
66 | post-bmv | 1 |
67 | pre-nutrition | 1 |
68 | pretargeted | 1 |
69 | protocol-prescribed | 1 |
70 | quinolone-3-carboxamide | 2 |
71 | rage-oriented | 1 |
72 | ribavirin- | 1 |
73 | rifabutin-containing | 2 |
74 | rt-adjuvant | 1 |
75 | stem-based | 1 |
76 | tacrolimus-minimization | 1 |
77 | third-ranking | 1 |
78 | three-spasm-needle | 2 |
79 | thrombolytic-therapy-based | 1 |
80 | tmz-combination | 1 |
81 | tone-emitting | 3 |
82 | tranvesical | 1 |
83 | two-combination | 2 |
84 | vegfr-tki-based | 2 |
85 | who-multidrug | 1 |
86 | whole-planned | 1 |
1 | calcitriol- | 1 |
2 | ribavirin- | 1 |
3 | belatacept- | 1 |
4 | day-6 | 2 |
5 | anti-invadopodia | 1 |
6 | non-acei/arb | 8 |
7 | mortality.diabetes-specific | 1 |
8 | hypocholesterolic | 1 |
9 | exercise/music | 2 |
10 | protocol-prescribed | 1 |
11 | government/foundation-funded | 1 |
12 | whole-planned | 1 |
13 | bmmsc-based | 1 |
14 | ngf-based | 1 |
15 | ace-i-based | 1 |
16 | vegfr-tki-based | 2 |
17 | stem-based | 1 |
18 | thrombolytic-therapy-based | 1 |
19 | h.pylori-eradicated | 1 |
20 | cilastatin-treated | 1 |
21 | pretargeted | 1 |
22 | rage-oriented | 1 |
23 | phocid | 1 |
24 | macrolid | 2 |
25 | concomitance | 14 |
26 | quinolone-3-carboxamide | 2 |
27 | aminonucleoside | 2 |
28 | floating-needle | 7 |
29 | three-spasm-needle | 2 |
30 | deferasirox-ambisome | 1 |
31 | 1,3-diene | 1 |
32 | other-endocrine | 1 |
33 | medical-expulsive | 1 |
34 | third-ranking | 1 |
35 | anthracycline/taxane-containing | 1 |
36 | rifabutin-containing | 2 |
37 | tone-emitting | 3 |
38 | 1-year-long | 2 |
39 | who-multidrug | 1 |
40 | 3d-framework | 2 |
41 | oncolgical | 1 |
42 | 'oncological | 1 |
43 | ampirical | 1 |
44 | tranvesical | 1 |
45 | chronopharmaceutical | 1 |
46 | anti-microsporidial | 1 |
47 | dietary-behavioral | 1 |
48 | ektachem | 1 |
49 | going-on | 1 |
50 | infiusion | 1 |
51 | induction/consolidation | 3 |
52 | eortc-radiation | 1 |
53 | photodynamic/radiation | 1 |
54 | coformulation | 6 |
55 | 1-hydroxylation | 2 |
56 | combination | 36,281 |
57 | half-dose-combination | 2 |
58 | two-combination | 2 |
59 | tmz-combination | 1 |
60 | children.combination | 1 |
61 | adjunct/combination | 1 |
62 | co-vaccination | 2 |
63 | peripheralization | 7 |
64 | tacrolimus-minimization | 1 |
65 | oncology/infection | 1 |
66 | exposure/extinction | 1 |
67 | pre-nutrition | 1 |
68 | late-intervention | 3 |
69 | design/execution | 2 |
70 | 'comparison | 5 |
71 | glutamine-group | 3 |
72 | hetero-oligomer | 3 |
73 | azaindolyl-maleimides | 1 |
74 | nectaries | 4 |
75 | co-diagnosis | 2 |
76 | 12-sessions | 3 |
77 | ag013-subjects | 1 |
78 | immunoresolvents | 1 |
79 | chop-rit | 3 |
80 | co-contaminant | 2 |
81 | rt-adjuvant | 1 |
82 | fluid-replacement | 1 |
83 | millisievert | 2 |
84 | post-bmv | 1 |
85 | hdm/sct-only | 1 |
86 | co-delivery | 4 |